Clinical Trials Browser

Terminated × Interventional × Microsatellite Instability × Clear all

NCT06625515 2026-02-24

First-in-Human Study of ATX-559, an Oral Inhibitor of DHX9, in Patients With Advanced or Metastatic Solid Tumors, and Molecularly Defined Cancers

Phase 1 Terminated

GastrointestinalGynecologic

Colonic Neoplasms, Rectal Neoplasms, Endometrial Neoplasms, Microsatellite Instability

NCT03827044 2022-10-07

POLEM

Phase 3 Terminated

Gastrointestinal

Colonic Neoplasms, Microsatellite Instability